After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

NeuroSolve is a four-year project funded by the European Commission and EDCTP3, started on May 1, 2023. The African Institutions involved are: University of Dar es Salaam (Tanzania), Sokoine University of Agriculture (Tanzania), University of Zambia (Zambia); the European Institutions are: Universiteit Ghent (Belgium) and R-Evolution Worldwide Srl – Impresa Sociale (Italy), that is also the project Coordinator. NeuroSolve is committed to fight taeniasis/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.

Potrebbe essere un'immagine raffigurante testo

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Neglected Tropical Diseases affect 1 in 5 people in the world

Neglected Tropical Diseases affect 1 in 5 people worldwide. Affecting over 1.7 billion people, the Neglected Tropical Diseases impair physical and cognitive development, contribute to mother and child illness and

Read More

INTEGRATION Annual Project Meeting Y2-Rome

The INTEGRATION consortium held its annual meeting of the year 2 of the project on 6th and 7th March 2023 in Rome, Italy. During the meeting, the progress of the

Read More

R-Evolution Worldwide – Sierra Leone, a new local Community Based Organization

R-Evolution Worldwide – Sierra Leone is starting to operate in the Western Area Urban and Rural District of Freetown, Sierra Leone. R-Evolution Worldwide – Sierra Leone is local community-based organization, registered to

Read More